INVO Fertility Reports Unregistered Equity Sale
Ticker: IVF · Form: 8-K · Filed: Sep 12, 2025 · CIK: 1417926
Sentiment: neutral
Topics: unregistered-sale, equity-securities, capital-raise
TL;DR
INVO Fertility sold unregistered shares on 9/8/25 - details TBD.
AI Summary
On September 8, 2025, INVO Fertility, Inc. reported an unregistered sale of equity securities. The filing does not disclose the specific number of shares sold, the price per share, or the total dollar amount of the transaction, only that it occurred.
Why It Matters
This filing indicates a potential dilution of existing shares or a capital raise through private means, which could impact the stock price.
Risk Assessment
Risk Level: medium — Unregistered sales can signal financial distress or a need for capital, and the lack of specific details raises concerns about the terms of the sale.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- September 8, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Sarasota, FL 34240 (location) — Principal executive offices address
FAQ
What type of equity securities were sold?
The filing does not specify the type of equity securities sold, only that it was an unregistered sale.
How many shares were sold in this unregistered offering?
The filing does not disclose the number of shares sold.
What was the price per share for the unregistered equity sale?
The filing does not provide the price per share for the unregistered equity sale.
What was the total dollar amount of the unregistered equity sale?
The filing does not disclose the total dollar amount of the unregistered equity sale.
Who were the purchasers of these unregistered equity securities?
The filing does not identify the purchasers of the unregistered equity securities.
Filing Stats: 586 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-09-12 16:12:01
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
- $200,000 — rred, with an aggregate stated value of $200,000, for $200,000 in cash. As a result of t
- $0.7362 — price on the C-2 Preferred adjusted to $0.7362 per share. The C-2 Preferred issued pur
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001641172-25-027201.txt ( ) — 195KB
- ivf-20250908.xsd (EX-101.SCH) — 3KB
- ivf-20250908_lab.xml (EX-101.LAB) — 33KB
- ivf-20250908_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 12, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer